GSK plc (LON:GSK)
1,854.50
+84.00 (4.74%)
Sep 14, 2026, 4:53 PM GMT
GSK plc Employees
GSK plc had 66,841 employees as of December 31, 2025. The number of employees decreased by 1,788 or -2.61% compared to the previous year.
Employees
66,841
Change (1Y)
-1,788
Growth (1Y)
-2.61%
Revenue / Employee
496.75K GBP
Profits / Employee
72.13K GBP
Market Cap
70.94B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66,841 | -1,788 | -2.61% |
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 96,100 |
| Haleon | 24,535 |
| Spire Healthcare Group | 17,800 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 9,000 |
| Genus | 3,190 |
GSK plc News
- 2 hours ago - GSK Shares Jump 3.83% as Twin Lung Cancer Drug Trial Wins Reinforce Its Growing Oncology Pipeline Bet - International Business Times (Australia)
- 7 hours ago - GSK's Jideytro & Ris-Rez Show Positive Data In Two Lung Cancer Studies - Nasdaq
- 13 hours ago - Data from Greater Bay Area’s 88 million residents to help improve healthcare policy: GSK - South China Morning Post
- 16 hours ago - GSK Looks 5.5% Overvalued on GF Value⢠as Dividend Sustainability Remains Key - GuruFocus
- 17 hours ago - GSK presents results from phase I/II ARROS-1 trial evaluating Jideytro - TheFly
- 1 day ago - GSK Looks 5.5% Overvalued on GF Value⢠as Dividend Sustainability Remains a Key Focus - GuruFocus
- 1 day ago - GSK licensor Hansoh announces ARTEMIS-008 phase III trial met primary endpoint - TheFly
- 1 day ago - GSK Targets £1.9B Savings to Fuel Pipeline, Navigate HIV Patent Cliff - MarketBeat